Covid-19 Or Common Cold? When Should You Get Tested? Here Are The Guidelines
India is currently witnessing a resurgence in Covid-19 cases. According to the Health Ministry data, 4302 active Covid cases have been recorded in the country as of today. The new variants LF.7 and NB.1.8.1 are spreading rapidly, leading to mild to moderate symptoms. The Indian Council of Medical Research (ICMR) has stated that both variants are highly transmissible, although they predominantly cause mild illness.
With the onset of rain and frequent weather changes, there has also been an increase in flu-like illnesses in recent weeks. Covid-19 can present symptoms that overlap with those of the common cold, making it challenging to distinguish between the two. Therefore, testing remains an effective measure for detecting a potential Covid-19 infection.
Keep reading to understand the difference between a common cold and Covid-19 and when should you get tested.
Common cold Vs Covid-19
The overlapping symptoms can make it difficult to differentiate between a cold and Covid-19. However, being aware of the symptoms can help.
Common symptoms of the new Covid-19 strains include fever, cough, sore throat, headache, loss of appetite, body aches, fatigue, and a runny nose. Some infected individuals may also experience gastrointestinal issues and loss of taste and smell.
In contrast, common cold symptoms generally include a runny or stuffy nose, sneezing, a sore or scratchy throat, and a mild cough with fever. Individuals with a common cold usually do not experience a loss of smell or taste, gastrointestinal issues, and fatigue to the same extent as those with Covid-19.
However, due to the extreme similarities, covid can be easily mistaken for common cold and vice versa.
When should you test for covid?
According to the health ministry, symptomatic individuals need a covid test if:
They have a history of international travel in the last 14 days
They came in contact with confirmed cases
They are a healthcare provider
They are hospitalized patients with Severe Acute Respiratory Illness (SARI) influenza-like illness (ILI) or severe pneumonia.
Asymptomatic people who came in contact with infected individuals should be tested once between day 5 and day 14 of coming in his/her contact.
The guidelines also mention that all individuals need not be tested as most cases are reported in individuals with a travel history to the affected countries or close contacts of positive cases.
Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 hours ago
- Time of India
All adults overweight in every 5th Indian household: Study
Danny generated AI Image NEW DELHI: In nearly two out of 10 households, all adults are either overweight or obese, a new study has found. Overweight is defined as a body weight higher than what is considered healthy for a given height, commonly assessed using Body Mass Index (BMI). A person is considered overweight if his or her BMI is between 25 and 29.9 kg/m2. On the other hand, obesity is defined as a BMI of 30.0 kg/m2 or greater. Researchers from ICMR-National Institute for Cancer Prevention and Research (NICPR), TERI School of Advanced Studies and Symbiosis International analysed data from the fifth round of National Family Health Survey (NFHS-5, 2019-21) to assess the prevalence of overweight and obesity in over 6 lakh households. They found nearly 20% of the households had all adult members classified as overweight while 10% of households had all adults classified as obese. In states such as Manipur, Kerala, Arunachal Pradesh and Sikkim, over 30% of households had all adults overweight, according to the study, which was published in Public Health Journal. In Tamil Nadu and Punjab, two out of five households had all adults classified as obese. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 2025 Top Trending Local Enterprise Accounting Software [Click Here] Accounting ERP Click Here Undo The proportion of households with all obese members was nearly twice as high in urban areas compared to rural regions. A weighty issue The study reveals that families are literally 'gaining weight together'. When one family member is overweight or obese, others are significantly more likely to be obese/overweight as well, said the lead researcher from ICMR-NICPR Prashant Kumar Singh. "This clustering pattern underscores the urgent need for family-centred approaches to obesity prevention rather than individual-focused interventions." Director ICMR-NICPR Shalini Singh, said, "The household clustering of obesity and overweight represents a paradigm shift in how we understand obesity. This study tells us the family unit is the epicentre of this health challenge." The study warned that individuals in these family obesity clusters face heightened risk of developing multiple non-communicable diseases. It is already known that obesity serves as a marker for poor cardio-metabolic health and is known to be a gateway to numerous chronic conditions like diabetes, hypertension, stroke, and heart failure. It is also linked to 13 types of cancer.
Time of India
5 hours ago
- Time of India
Four test positive for Covid-19
Four men tested positive for Covid-19 in the city on Saturday. The new cases include an 85-year-old from Telibagh, a 38-year-old, a 58-year-old from Mohanlalganj, and a 19-year-old from Chowk. With these additions, the total number of Covid-positive patients reported in the district reached 66, of which 35 are currently active.
India Gazette
6 hours ago
- India Gazette
Home grown less than 50 rupees' test aiding fight against Sickle Cell Disease
New Delhi [India], June 21 (ANI): Sickle Cell Disease, a genetic blood disorder, leads to severe health complications such as anaemia, frequent pain episodes and other debilitating symptoms, affecting millions worldwide, especially in India and Africa. According to Dr Prabhakar Kedar, Scientist F, ICMR- CRMCH, Chandrapur India has indigenous validated 35 company kits and 23 kits with 100 % accuracy and low cost for Sickle Cell Anaemia detection, 'we have validated so far 35 company kits and 23 have shown 100 per cent sensitivity and 12 kits 95 per cent sensitivity.' The sample collection is done from a finger prick mixed with buffer solution, and results are obtained in a few minutes. 'A drop of capillary blood (usually from a finger prick) is collected. 2. The blood is mixed with buffer solution and placed on the test strip or cassette, 3. Reaction: The test uses antibodies to detect different haemoglobin variants (HbA, HbS and control band).' He explained 'Colored lines appear on the strip within 10 minutes to indicate the presence of normal haemoglobin (HbA), sickle haemoglobin (HbS), and control band.' He said. On utilisation of these kits, he said 2 kits per month are used, and for each kit we use 50 Sickle homozygous blood samples, 50 heterozygous and 50 normal blood samples.' 'We used blood samples, which were first confirmed by the HPLC method, which is the gold standard for diagnosing sickle cell anaemia, ' he said. To support the fight against Sickle Cell Disease (SCD), two centres- ICMR-NIIH in Mumbai and CRMCH in Chandrapur, have been officially chosen by the government to test and approve new diagnostic kits. 'ICMR NIRRCH, along with PGI Chandigarh and ICMR-NIIH, conducted a comprehensive assessment and determined that point-of-care tests for Sickle Cell Disease/Trait among the high-risk population in India would be cost-effective if procured at INR 100 per test or below. Following the HTA recommendation, the National Health Mission instructed state health departments to procure the diagnostic kits at a maximum price of INR 100 per test. Through public tendering, the competitive procurement process drove the price of the kits down to INR 82 per test, significantly below the initial quote, resulting in a saving of Rs 1,857 crores. Subsequently, ICMR-NIIH has validated new kits, and further to it, the manufacturer has agreed to sell the kits at INR 50 per test,' states ICMR-CRMCH. These efforts are a big boost for the National Sickle Cell Elimination Mission, which aims to eliminate the disease from India by 2047. (ANI)
